Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM-1 in Short-Term Insomnia Phase Advance Model
NCT02671760Phase 2Completed
- Sponsor
- Sequential Medicine Ltd.
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of diphenhydramine in Short-term insomnia (3 arms), sponsored by Sequential Medicine Ltd. Primary endpoint: Total Sleep Time at 8 hours. Started Feb 2016; status: completed.
02
Drugs
diphenhydramine
03
Conditions
Short-term insomnia
Beyond the preview
Go deeper on NCT02671760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02671760.